Product Description
The global neurovascular guidewire market was valued at approximately $450 million in 2025. This is expected to increase over the forecast period at a CAGR of 7.6% to reach $750 million.
The full report suite covers the global market for neurovascular guidewires and includes complete market analyses (units, ASPs, and market values).
The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Neurovascular Guidewire Market Trends
Unit demand for neurovascular guidewires is expected to grow steadily, supported by aging populations and increasing volumes of endovascular procedures. Growth will be stronger in emerging markets as access to neurointerventional care expands, while mature markets remain relatively stable due to high penetration. However, continued pricing pressure, competitive dynamics and procurement strategies are expected to drive ASP declines, limiting overall market value growth.
Global Neurovascular Guidewire Market Share Insights
- Stryker was the leader in the global neurovascular guidewire market in 2025. The Synchro® has been a market leader since its launch. Additionally, Stryker sells the Transcend® product line of guidewires.
- Scientia Vascular held the second-leading position in the neurovascular guidewire market by providing two product families, the Aristotle® and the ZoomWire®.
- Medtronic was the third-leading competitor in the neurovascular guidewire market in 2025. The company competes in the market with its Mirage™ .008 guidewire, SilverSpeed® guidewire, X-Celerator™ hydrophilic guidewire and the X-Pedion™ guidewire.
Global Neurovascular Guidewire Market Segmentation Summary
- Neurovascular Guidewire Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
